Pillstats
Rx only · Tablet · Oral

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate

Amphetamine Aspartate Monohydrate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US13 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3288
US makers3 labelers
Packages19
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.084$0.167$0.251$0.335Dec 2025Apr 2026Jul 2026
$0.275
Latest avg · Jul 22, 2026
-5%
Since Dec 17, 2025
3
Active US suppliers
79%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

119K239K358K477K2025 Q12025 Q22025 Q32025 Q42026 Q1
362K
Rx · 2026 Q1
16.7M
Units dispensed
+4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager8SUPPLYING
Rhodes Pharmaceuticals LLCunknown7SUPPLYING
Sandoz Incunknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 12, 2022
    SHORTAGEDrug shortage: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (Sandoz Inc.)

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — reported in shortage by Sandoz Inc.. Therapeutic category: Psychiatry.